drugset / Trial / NCT03598868
Vortioxetine add-on Treatment Improves the Symptoms in Patients With Bipolar Depression
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to validate the efficacy of Vortioxetine augmentation in bipolar disorder patients with depressive symptoms.
Timeline
- Start
- 2018-08-08
- Primary completion
- 2021-09-25
- Completion
- 2021-09-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vortioxetine | Unknown | 5 mg | Oral |
| Subject | Vortioxetine | Unknown | 20 mg | Oral |